Product Information
CHLORHEXIDINE 0.12% RINSE is a generic product labeled by Xttrium Laboratories, Inc., priced at $0.0073 per ML under NDC 00116200116. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Jun 18, 2009. Its Orange Book therapeutic-equivalence code is AT.
Strength
1.2 mg/mL
Manufacturer
Xttrium Laboratories, Inc.NDC
00116200116
Classification
Generic
Dosage Form
RINSE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CHLORHEXIDINE GLUCONATEApproval Type
Generic (ANDA)
FDA Application
ANDA077789FDA Approved
6/18/2009
TE Code
AT
On Market Since
6/1/2010
Pharmacological Classes
Price Statistics
The NADAC for CHLORHEXIDINE 0.12% RINSE has been published 671 times since Nov 28, 2013, and over the history we have for it it has risen 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0073 per ML |
|---|---|
| All-time high | $0.0077 (Nov 13, 2024) |
| All-time low | $0.0044 (Jan 17, 2024) |
| 52-week high | $0.0075 |
| 52-week low | $0.0071 |
| Median price | $0.0059 |
| Average price | $0.0060 |
| Largest weekly change | +59.4% (Mar 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Xttrium Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Chlorhexidine Gluconate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CHLORHEXIDINE 0.12% RINSE?
The current National Average Drug Acquisition Cost (NADAC) for CHLORHEXIDINE 0.12% RINSE, manufactured by Xttrium Laboratories, Inc., is $0.0073 per ML (NDC 00116200116), effective Sep 30, 2026.
How has the price of CHLORHEXIDINE 0.12% RINSE changed over time?
Over the history we have for it, the NADAC for CHLORHEXIDINE 0.12% RINSE has risen 50.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CHLORHEXIDINE 0.12% RINSE?
Since Nov 28, 2013, the NADAC for CHLORHEXIDINE 0.12% RINSE has ranged from a low of $0.0044 (Jan 17, 2024) to a high of $0.0077 (Nov 13, 2024), with a median of $0.0059 per ML.
Are there cheaper alternatives to CHLORHEXIDINE 0.12% RINSE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CHLORHEXIDINE 0.12% RINSE in a comparable dosage form, but none are currently priced below it.
Who manufactures CHLORHEXIDINE 0.12% RINSE?
CHLORHEXIDINE 0.12% RINSE (NDC 00116200116) is labeled by Xttrium Laboratories, Inc., and CMS classifies it as a generic product.